DISCLAIMER: All products are intended solely for laboratory and research use and are not for human or animal consumption, injection, inhalation, transdermal application, compounding, clinical or diagnostic use, or for use in medical devices, cosmetics, food, or drug applications.
Share
Description:
GLP-1 R 30 MG (Retatrutide) | For research use only
Retatrutide is a next-generation investigational peptide designed to target multiple pathways. It is a triple agonist, meaning it activates GLP-1 (glucagon-like peptide-1), GIP (glucose- dependent insulinotropic polypeptide) and glucagon receptors making it one of the most comprehensive peptide candidates in obesity, insulin resistance and metabolic research. This triple-receptor activation is researched for synergistic effects on appetite regulation, blood sugar control, fat loss and energy expenditure.
